Lam Research Corporation $LRCX Stake Raised by Cim Investment Management Inc.
by Sarita Garza · The Markets DailyCim Investment Management Inc. raised its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 99.7% in the second quarter, Holdings Channel.com reports. The fund owned 19,658 shares of the semiconductor company’s stock after acquiring an additional 9,812 shares during the period. Cim Investment Management Inc.’s holdings in Lam Research were worth $1,914,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in LRCX. Marex Group plc bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $1,075,000. Advisory Services Network LLC grew its position in Lam Research by 11.3% in the second quarter. Advisory Services Network LLC now owns 162,346 shares of the semiconductor company’s stock worth $15,397,000 after buying an additional 16,494 shares during the last quarter. Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the second quarter valued at $30,000. Hohimer Wealth Management LLC lifted its position in shares of Lam Research by 1.3% during the 2nd quarter. Hohimer Wealth Management LLC now owns 48,509 shares of the semiconductor company’s stock valued at $4,722,000 after acquiring an additional 627 shares during the last quarter. Finally, Tactive Advisors LLC acquired a new stake in shares of Lam Research during the 2nd quarter valued at $407,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on LRCX shares. B. Riley boosted their target price on Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a research report on Monday, October 20th. Citigroup boosted their price objective on Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a report on Tuesday, November 11th. Needham & Company LLC upped their price objective on shares of Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Dbs Bank lifted their target price on shares of Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $170.00 price target on shares of Lam Research in a report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $152.87.
Check Out Our Latest Report on Lam Research
Lam Research Trading Down 4.9%
NASDAQ:LRCX opened at $160.52 on Friday. The stock has a market cap of $201.62 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $169.69. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The stock’s 50-day moving average is $152.53 and its two-hundred day moving average is $120.24.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period last year, the company posted $0.86 earnings per share. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.
Lam Research Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s payout ratio is currently 22.91%.
Insider Transactions at Lam Research
In related news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 102,608 shares of company stock valued at $14,916,496 in the last three months. 0.31% of the stock is currently owned by insiders.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
- Five stocks we like better than Lam Research
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
- How to trade penny stocks: A step-by-step guide
- Why Amazon Could Be a $300 Stock Within Weeks
- What is a Stock Market Index and How Do You Use Them?
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).